吉林敖东：子公司硫酸特布他林雾化吸入用溶液获得药品注册证书

Core Viewpoint - Jilin Aodong announced that its subsidiary Yanji Pharmaceutical has received a drug registration certificate from the National Medical Products Administration for "Sulfuric Terbutaline Nebulized Inhalation Solution," which is used to relieve bronchial asthma, chronic bronchitis, emphysema, and other lung diseases associated with bronchospasm [1] Group 1 - The drug registration certificate enhances the company's product structure [1] - The approval enriches the variety of products offered by the company [1] - This development strengthens the company's core competitiveness in the pharmaceutical industry [1]